The most common side effects of ezetimibe are upper respiratory tract infections, diarrhea, joint pain, sinus infections, and pain in the arms or legs. In clinical trials, these occurred in roughly 3% to 4% of patients, only slightly more often than in people taking a placebo. Overall, ezetimibe is considered one of the better-tolerated cholesterol-lowering medications, and most people take it without significant problems.
The Five Most Frequently Reported Side Effects
In placebo-controlled trials, the side effects that showed up in at least 2% of patients taking ezetimibe (and more often than placebo) were:
- Upper respiratory tract infection: 4.3% on ezetimibe vs. 2.5% on placebo
- Diarrhea: 4.1% vs. 3.7%
- Joint pain (arthralgia): 3.0% vs. 2.2%
- Sinusitis: 2.8% vs. 2.2%
- Pain in the arms or legs: 2.7% vs. 2.5%
Notice how close these numbers are to placebo in several cases. Diarrhea, for example, occurred in 4.1% of people on ezetimibe versus 3.7% on a sugar pill. That gap is small enough that some of these symptoms may not be caused by the drug at all. The most meaningful difference is with upper respiratory infections, where the rate was nearly double that of placebo.
Muscle Pain and Ezetimibe
If you’ve been prescribed ezetimibe because you couldn’t tolerate a statin, muscle pain is probably your biggest concern. The reassuring finding: a large systematic review and meta-analysis published in BMJ Medicine found that ezetimibe was not associated with muscle pain or weakness leading to discontinuation compared to placebo. Two of the studies included in that analysis reported zero instances of muscle pain during their entire follow-up period.
This makes ezetimibe a useful alternative for people who experience statin-related muscle symptoms. While occasional muscle aches are listed as a possible side effect, the clinical evidence consistently shows that the risk is no higher than what you’d see with a placebo.
What Happens When You Add Ezetimibe to a Statin
Many people take ezetimibe alongside a statin for extra cholesterol lowering, so a natural question is whether combining the two drugs makes side effects worse. A review of randomized clinical trials found that adding ezetimibe to statin therapy did not increase the risk of muscle pain, muscle enzyme elevations, muscle breakdown (rhabdomyolysis), liver enzyme elevations, gastrointestinal problems, or discontinuations due to adverse events. In short, the combination doesn’t appear to pile on additional side effects beyond what the statin alone would cause.
A meta-analysis of 18 randomized trials involving over 14,000 people confirmed that liver enzyme elevations on the combination were no different from those seen with a statin alone.
Effects on the Liver
Ezetimibe can affect liver enzymes, though the risk on its own is similar to placebo. Current guidelines recommend checking liver function tests before starting the medication and monitoring periodically during treatment. When used as a single drug, ezetimibe causes liver enzyme elevations at roughly the same rate as a sugar pill.
Clinically significant liver injury from ezetimibe is rare, but it has been documented. In the small number of reported cases, symptoms appeared between 2 and 10 months after starting the drug. Warning signs included loss of appetite, abdominal pain (particularly in the upper right area), itching, unusual tiredness, and yellowing of the skin or eyes. These cases ranged from mild to severe, with most resolving after stopping the medication. If you notice any of these symptoms, it’s worth contacting your doctor promptly.
Rare but Serious Reactions
Severe allergic reactions to ezetimibe are uncommon but documented. Postmarketing surveillance has identified angioedema, a rapid swelling of the face, lips, tongue, or throat, as a rare hypersensitivity reaction. Only two cases of ezetimibe-associated angioedema have been reported in the medical literature. In one case, the patient had been on the medication for multiple years before the reaction developed, which makes it tricky to connect the symptom to the drug right away.
Other serious but uncommon reactions reported through postmarketing data include skin rash, hives, difficulty breathing or swallowing, rapid heartbeat, and dizziness or fainting. These affect a very small fraction of users, but they require immediate medical attention if they occur.
Side Effects in Children
Ezetimibe is approved for children aged 10 and older who have inherited forms of high cholesterol. The side effect profile in this age group is similar to what’s seen in adults. The most commonly reported symptoms in pediatric patients include diarrhea, sore throat, runny nose, sneezing, and pain in the joints, back, arms, or legs. Serious reactions remain rare.
When Side Effects Typically Appear
Most of the common, mild side effects like diarrhea or joint aches tend to show up within the first few weeks of starting ezetimibe. Liver-related problems, when they occur at all, have a longer timeline. Case reports place the onset of liver injury anywhere from 2 to 10 months into treatment. One pattern seen in documented cases: a patient feels fine for several months, then develops vague symptoms like fatigue, stomach discomfort, or itching that gradually worsen.
This delayed onset is worth keeping in mind. If you develop new, unexplained symptoms months after starting ezetimibe, the medication is still a possible contributor even if you tolerated it well initially.